Skip to content

Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF)

Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF): Randomized, Double-blind, Controlled Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06002217
Acronym
TAP ALIF
Enrollment
80
Registered
2023-08-21
Start date
2024-02-05
Completion date
2026-07-09
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fusion of Spine, Lumbar Region

Brief summary

The goal of this interventional study is to is to compare the effect of a tap block versus a placebo in patients undergoing anterior lumbar spine surgery. The main question it aims to answer : • whether tap block can reduce the need for postoperative pain medication Participants will be randomized into two groups and all postoperative pain medication will be recorded over 3 days. Researchers will compare tap block vs placebo to see if it reduces postoperative pain.

Interventions

DRUGLevobupivacaine

Patients in the tap block arm will receive an injection of levobupivacaine 2.5mg/ml

Patients in the placebo arm will receive an injection of salin solution 2.5mg/ml , in the same way as tap block

Sponsors

Clinique Saint Jean, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient affiliated or entitled to a social security plan. * Patient who has been informed about the study and has co-signed a consent form with the investigator. consent to participate in the study. * Patients over 18 years of age scheduled for abdominal disc surgery on one or two levels. * Patient with ASA criteria 1, 2 and 3.

Exclusion criteria

* Patients with intolerance or contraindication to paracetamol, anti-inflammatory or morphine. * Patients allergic to local anesthetics. * Pregnant or breast-feeding patient. * patient undergoing cancer or trauma surgery trauma. * Patient participating in another interventional study. * Patient with a history of lumbar arthrodesis. * Patient refusing to sign consent form. * Patient unable to give informed consent. * Patient under court protection, guardianship or trusteeship. * Patient not available for study follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Analgesic consumption72hoursThe use of analgesics (oral or venous) during the during the 72 hours following surgery

Secondary

MeasureTime frameDescription
Pain assessment will be reported for 72 hours after surgery measured on a Visual analogue scale between 0 and 1072hoursPain assessment for 72 hours after surgery, measured on a scale between 0 and 10 (VAS scale ), where 0 is no pain and 10 is maximum pain

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026